What is Beijing Aosaikang Pharmaceutical Co., Ltd.'s (002755.SZ) StockRank?

MoatMap's StockRank for Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) is 35/100, with a Hold signal. This is a composite score combining Quality (73), Value (23), and Momentum (31) factor ranks across MoatMap's 19,000+ stock universe.

Does Beijing Aosaikang Pharmaceutical Co., Ltd. have an economic moat?

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Aosaikang Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) is Hold, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Aosaikang Pharmaceutical Co., Ltd. in?

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002755.SZ

HOLDREMOVE

Beijing Aosaikang Pharmaceutical Co., Ltd. · Healthcare · China · $2.0B · Avg Vol: $32M/d

StockRank

P/E (TTM)

46.5x

ROE

8.1%

D/E

0.0x

Dividend %

0.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Aosaikang Pharmaceutical is a domestic Chinese drug manufacturer. It lacks the global scale, validated regulatory moats, and third-party pricing power required to benefit from our CDMO theme.

COMPANY DESCRIPTION

Beijing Aosaikang Pharmaceutical Co., Ltd. develops, manufactures, and markets specialty pharmaceutical products, with a focus on oncology and digestive system therapeutic areas. The company is a leading domestic producer of proton pump inhibitor (PPI) injections, holding a significant market share in China's hospital market. It is characterized by its strong R&D pipeline in innovative oncology drugs and a highly specialized clinical sales force.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	277M	213M	263M	263M	-1.7%
EPS	-0.04	-0.02	0.03	0.04	47.1%
Shares	928M	928M	928M	928M	0.0%
Debt	8M	18M	11M	5M	-16.2%
Equity	438M	429M	453M	475M	2.8%
Op CF	-8M	-4M	61M	96M	58.4%
Inv CF	-65M	2M	-26M	-65M	—
Fin CF	11M	43M	6M	-18M	—

PRICE (1M)-23.6%

SMA 50SMA 200

$1.89

RSI (14)

16.6

52W High

$4.29

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

7.6%65.4

ROE

8.1%66.1

GP/Assets

31.4%67.0

Op. Margin

21.7%84.9

FCF/Assets

5.0%70.7

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.00x96.2

Current Ratio

2.73x49.1

Value

P/E (TTM)

46.5x22.2

EV/EBITDA

25.1x14.2

P/FCF

405.5x20.5

P/B

3.7x32.4

P/S

6.9x33.0

Div Yield

0.9%24.9

Momentum

52W High %

44%17.2

RS 6M

-33%38.0

SMA 50/200

0.88x27.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—4.8

Q Growth

54%77.7

FUNDAMENTALS

Market Cap

$2.0B

P/E (Forward)

1303.0x

Gross Margin

80.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002755.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002755.SZ	Beijing Aosaikang Pharmaceutical Co., Ltd.(you)	$2.0B	35	HOLD
000534.SZ	Wedge Industrial Co.,Ltd.	$2.5B	39	HOLD
6887.HK	Sunshine Lake Pharma Co., Ltd.	$2.7B	30	SELL
300267.SZ	Hunan Er-Kang Pharmaceutical Co., Ltd	$1.1B	34	SELL
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
688091.SS	Shanghai Yizhong Pharmaceutical Co., Ltd.	$1.4B	27	SELL
300026.SZ	Tianjin Chase Sun Pharmaceutical Co.,Ltd	$1.4B	43	HOLD
300723.SZ	ApicHope Pharmaceutical Group Co., Ltd.	$2.9B	27	SELL
300601.SZ	Shenzhen Kangtai Biological Products Co., Ltd.	$2.1B	51	HOLD
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.	$2.3B	50	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) — Stock Score Summary

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) has a MoatMap StockRank of 35/100 based on Quality (73/100), Value (23/100), and Momentum (31/100) factor scores. The current signal is HOLD. Beijing Aosaikang Pharmaceutical is a domestic Chinese drug manufacturer. It lacks the global scale, validated regulatory moats, and third-party pricing power required to benefit from our CDMO theme.

Key Financial Metrics

Price	$1.89
Market Cap	$2.0B
P/E (TTM)	46.54
P/E (Forward)	1303.00
Price/Book	3.66
Return on Equity	8.1%
Return on Invested Capital	7.6%
Debt/Equity	0.19
Gross Margin	80.5%
Operating Margin	21.7%
Revenue Growth	-5.3%
Dividend Yield	0.9%
Free Cash Flow	$5M

Beijing Aosaikang Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Aosaikang Pharmaceutical Co., Ltd.’s (002755.SZ) StockRank?: MoatMap’s StockRank for Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) is 35/100, with a Hold signal. It is a composite of Quality (73), Value (23), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Aosaikang Pharmaceutical Co., Ltd. have an economic moat?: Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Aosaikang Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) is Hold, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Aosaikang Pharmaceutical Co., Ltd. in?: Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).